$11.21
+2.09%
N/A+$0.23
Healthcare
Medical - Devices
NASDAQ
Active Trading
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the ...
Loading analysis...
Profitability
Net MarginN/A
Operating MarginN/A
Valuation
P/E RatioNaNx
Current RatioN/A
Efficiency
ROE-4.85%
ROA2.64%
Fundamental Analysis
AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
Key Strengths
- Industry-leading gross margins
- Strong cash flow generation
- High R&D investment ratio
- Market leadership in AI chips
Risk Factors
- Premium valuation multiples
- Semiconductor cycle exposure
- Intense competition
- Geographic concentration
Market Cap vs Revenue & Earnings
Earnings
n/a
Revenue
n/a
Market cap
$1.53B
n/a
P/E Ratio
n/a
P/S Ratio
Earnings & Revenue
Last Reportedn/a
Earnings per share (EPS)n/a
Gross Marginn/a
Net Profit Marginn/a
Debt/Equity Ration/a
Profitability Bridge (Current vs YoY)
How gross, operating and net margins shifted versus last year.
Revenue / Net Income / FCF History (USD B)
Growth Signals
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | Flat |
| Diluted EPS | — | — | — | — | Flat |
| Free Cash Flow | — | — | — | — | Flat |
Profitability
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Net Margin | — | -1.96% | — | — | Flat |
| Operating Margin | — | 0.84% | — | — | Flat |
| ROE | — | — | — | — | Flat |
Financial Health
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| Current Ratio | — | 0.925 | — | — | Flat |
| Quick Ratio | — | 0.711 | — | — | Flat |
| Debt / Equity | — | 1.328 | — | — | Flat |
Valuation
| Metric | Current | Previous | YoYYear-over-Year change: current quarter versus the same quarter last year. | QoQQuarter-over-Quarter change: current quarter versus the immediately previous quarter. | Signal |
|---|---|---|---|---|---|
| P/E | — | -25.35x | — | — | Flat |
| P/B | — | 1.10x | — | — | Flat |